-
EP3773483
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3773483
| EP3773483 - COMPOSITION FOR CONTROLLED RELEASE OF THERAPEUTIC AGENTS [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 15.01.2021 Database last updated on 11.05.2024 | |
| Former | The international publication has been made Status updated on 12.10.2019 | Most recent event Tooltip | 26.02.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Amma Therapeutics, Inc. 31162 San Clemente Street, 100 Hayward CA 94544 / US | [2021/07] | Inventor(s) | 01 /
SEKAR, Michael M. c/o AMMA Therapeutics, Inc. 31162 San Clemente Street, 100 Hayward, California 94544 / US | 02 /
SINGHAL, Manish c/o AMMA Therapeutics, Inc. 31162 San Clemente Street, 100 Hayward, California 94544 / US | [2021/07] | Representative(s) | Wohlfahrt, Jan Günther, et al Gleiss Große Schrell und Partner mbB Patentanwälte Rechtsanwälte Leitzstraße 45 70469 Stuttgart / DE | [2021/07] | Application number, filing date | 19780606.0 | 05.04.2019 | [2021/07] | WO2019US26120 | Priority number, date | US201862653951P | 06.04.2018 Original published format: US 201862653951 P | [2021/07] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019195766 | Date: | 10.10.2019 | Language: | EN | [2019/41] | Type: | A1 Application with search report | No.: | EP3773483 | Date: | 17.02.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 10.10.2019 takes the place of the publication of the European patent application. | [2021/07] | Search report(s) | International search report - published on: | US | 10.10.2019 | (Supplementary) European search report - dispatched on: | EP | 23.12.2021 | Classification | IPC: | A61K9/00, A61K38/04, A61K38/08, A61K38/10, A61K38/16, A61K47/42, C07K7/00 | [2021/07] | CPC: |
A61K31/135 (EP,US);
A61K9/0014 (KR);
A61K38/10 (US);
A61K31/445 (KR);
A61K31/451 (EP,US);
A61K38/08 (US);
A61K38/1709 (US);
A61K38/26 (EP,KR);
A61K38/28 (EP,KR,US);
A61K45/06 (KR);
A61K47/42 (KR);
A61K9/0053 (KR);
C07K14/001 (KR);
C07K14/7151 (US);
C07K7/06 (EP);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/07] | Title | German: | ZUSAMMENSETZUNG ZUR KONTROLLIERTEN FREISETZUNG VON THERAPEUTIKA | [2021/07] | English: | COMPOSITION FOR CONTROLLED RELEASE OF THERAPEUTIC AGENTS | [2021/07] | French: | COMPOSITION POUR LA LIBÉRATION CONTRÔLÉE D'AGENTS THÉRAPEUTIQUES | [2021/07] | Entry into regional phase | 06.11.2020 | National basic fee paid | 06.11.2020 | Search fee paid | 06.11.2020 | Designation fee(s) paid | 06.11.2020 | Examination fee paid | Examination procedure | 06.11.2020 | Examination requested [2021/07] | 17.08.2022 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time | 21.10.2022 | Amendment by applicant (claims and/or description) | Request for further processing for: | The application is deemed to be withdrawn due to failure to indicate the wish to proceed further with the application | 21.10.2022 | Request for further processing filed | 21.10.2022 | Full payment received (date of receipt of payment) Request granted | 02.11.2022 | Decision despatched | The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report | 21.10.2022 | Request for further processing filed | 21.10.2022 | Full payment received (date of receipt of payment) Request granted | 02.11.2022 | Decision despatched | Fees paid | Renewal fee | 15.04.2021 | Renewal fee patent year 03 | 02.03.2022 | Renewal fee patent year 04 | 27.02.2023 | Renewal fee patent year 05 | 26.02.2024 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO0147549 (UNIV LONDON [GB], et al) [X] 14,15* claim 26 *; | [X]WO2004018519 (QUEEN MARY & WESTFIELD COLLEGE [GB], et al) [X] 14,15 * page 4 *; | [XI]US2010137187 (BARTON BEVERLY E [US], et al) [X] 1-6,8-10,12-15 * the whole document * * page 2, paragraph 11; table 1 * [I] 1-15; | [XI] - ANTONELLA BORRELLI ET AL, "Cell Penetrating Peptides as Molecular Carriers for Anti-Cancer Agents", MOLECULES, (20180131), vol. 23, no. 2, doi:10.3390/molecules23020295, pages 1 - 28, XP055633649 [X] 1-6,8-10,12-15 * the whole document * * table 1 * [I] 1-15 DOI: http://dx.doi.org/10.3390/molecules23020295 | [I] - BRIUGLIA MARIA-LUCIA ET AL, "Sustained and controlled release of lipophilic drugs from a self-assembling amphiphilic peptide hydrogel", INTERNATIONAL JOURNAL OF PHARMACEUTICS, ELSEVIER, NL, (20140820), vol. 474, no. 1, doi:10.1016/J.IJPHARM.2014.08.025, ISSN 0378-5173, pages 103 - 111, XP029064369 [I] 1-15 * the whole document * * page 103 * DOI: http://dx.doi.org/10.1016/j.ijpharm.2014.08.025 | [I] - ESKANDARI SHARAREH ET AL, "Recent advances in self-assembled peptides: Implications for targeted drug delivery and vaccine engineering", ADVANCED DRUG DELIVERY REVIEWS, ELSEVIER, AMSTERDAM , NL, (20160626), vol. 110, doi:10.1016/J.ADDR.2016.06.013, ISSN 0169-409X, pages 169 - 187, XP085062901 [I] 1-15 * the whole document * * page 174 * DOI: http://dx.doi.org/10.1016/j.addr.2016.06.013 | [I] - KOPECEK J ET AL, "Peptide-directed self-assembly of hydrogels", ACTA BIOMATERIALIA, ELSEVIER, AMSTERDAM, NL, vol. 5, no. 3, doi:10.1016/J.ACTBIO.2008.10.001, ISSN 1742-7061, (20081014), pages 805 - 816, (20081014), XP025990678 [I] 1-15 * the whole document * * page 806 - page 807 * DOI: http://dx.doi.org/10.1016/j.actbio.2008.10.001 | [I] - MENG QINGBIN ET AL, "Tunable Self-Assembled Peptide Amphiphile Nanostructures", LANGMUIR, US, (20120320), vol. 28, no. 11, doi:10.1021/la3003355, ISSN 0743-7463, pages 5017 - 5022, XP055872694 [I] 1-15 * the whole document * * table 1 * DOI: http://dx.doi.org/10.1021/la3003355 | [X] - SHEN XINCHUN ET AL, "Adhesion and Structure Properties of Protein Nanomaterials Containing Hydrophobic and Charged Amino Acids", JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, US, (20060301), vol. 6, no. 3, doi:10.1166/jnn.2006.126, ISSN 1533-4880, pages 837 - 844, XP055871578 [X] 14,15 * table 1 * DOI: http://dx.doi.org/10.1166/jnn.2006.126 | [X] - ZHENG XIAOYAO ET AL, "Intranasal H102 Peptide-Loaded Liposomes for Brain Delivery to Treat Alzheimer's Disease", PHARMACEUTICAL RESEARCH, SPRINGER US, NEW YORK, vol. 32, no. 12, doi:10.1007/S11095-015-1744-9, ISSN 0724-8741, (20150626), pages 3837 - 3849, (20150626), XP035579862 [X] 14,15 * page 3838 * DOI: http://dx.doi.org/10.1007/s11095-015-1744-9 | International search | [A]US4675381 (BICHON DANIEL [FR]) [A] 1-4, 29-33, 42, 43* entire document *; | [A]WO0147549 (UNIV LONDON [GB], et al) [A] 1-4, 29-33, 42, 43 * entire document *; | [A]WO2004043432 (ALZA CORP [US], et al) [A] 1-4, 29-33, 42, 43 * entire document *; | [A]US2011311594 (CHEN SHOU-CHIUNG [TW], et al) [A] 1-4, 29-33, 42, 43 * entire document *; | [A]WO2012131106 (INGELL TECHNOLOGIES HOLDING B V [NL], et al) [A] 1-4, 29-33, 42, 43 * entire document *; | [A] - PANDA et al., "Self-assembled nanoparticles based on modified cationic dipeptides and DNA: novel systems for gene delivery", Journal of Nanobiotechnology, (20130621), vol. 11, pages 1 - 13, XP021155450 [A] 1-4, 29-33, 42, 43 * . entire document * DOI: http://dx.doi.org/10.1186/1477-3155-11-18 |